InsidersTradesSigma
Follow the INTEGRAL DIAGNOSTICS LIMITED stock price and the full directors' dealings record of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the authority of ASX. Market capitalisation: €835.7m. The latest transaction was filed on 6 August 2026 (Other). Among the most active insiders: Jason Martinez Date of appointment 06 August 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust. The full history is accessible without an account.
Analysts rate INTEGRAL DIAGNOSTICS LIMITED Strong Buy (bullish), based on 14 analysts. Average price target: A$2.96.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
INTEGRAL DIAGNOSTICS LIMITED es una empresa que cotiza en el XASX, especializada en el sector de diagnósticos médicos. Proporciona servicios de diagnóstico e imágenes médicas para mejorar la atención al paciente.